Barlow Wealth Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
432
-1
-0.2% -$462 0.02% 137
2026
Q1
$225K Buy
433
+8
+2% +$4.1K 0.03% 129
2025
Q4
$253K Hold
425
0.03% 122
2025
Q3
$232K Buy
+425
New +$186K 0.03% 119
2025
Q1
Sell
-4,127
Closed -$1.38M 138
2024
Q4
$1.38M Buy
+4,127
New +$1.4M 0.18% 51

Other funds holding MEDP

Barlow Wealth Partners's MEDP Position: Q2 2026 in Review

Barlow Wealth Partners reduced its Medpace (MEDP) stake by 0.23% in Q2 2026, selling an estimated $462 and leaving 432 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #137.

Barlow Wealth Partners first reported a position in MEDP in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.38M in Q4 2024. 234 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Barlow Wealth Partners held 432 shares of Medpace worth $230K as of Q2 2026.
  • Barlow Wealth Partners sold 1 Medpace share in Q2 2026, an estimated $462.
  • Medpace made up 0.02% of Barlow Wealth Partners's portfolio in Q2 2026, its #137 holding.
  • Barlow Wealth Partners first reported a position in Medpace in Q4 2024 and has held it in 5 quarters since.
  • Barlow Wealth Partners's Medpace position peaked at $1.38M in Q4 2024.
  • 234 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Barlow Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.